SHANGHAI and HONG KONG, April 18, 2026 /PRNewswire/ -- Antengene Corporation Limited  ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, today announced that it has released present results from three novel programs in poster presentations at the 2026 American Association for Cancer Research Annual Meeting (AACR 2026). The presentations will feature ATG-125 (B7-H3 x PD-L1 bispecific antibody-drug conjugate [ADC]), an IO + ADC dual-function molecule being developed for the treatment of solid tumors, as well as two investigational T cell engagers (TCEs) developed using the company's proprietary AnTenGager^® TCE platform, including ATG-106 (CDH6 x CD3 TCE) for ovarian and kidney cancers, and ATG-112 (ALPPL2 x CD3 TCE) for gynecological tumors, digestive system malignancies, bladder cancer and NSCLC.

Details of the Poster Presentation:
ATG-125 (B7-H3 x PD-L1 bispecific ADC)
Title: ATG-125, a novel B7H3 x PD-L1 bispecific antibody-drug conjugate, demonstrates potent antitumor efficacy by dual targeting of immune evasion and direct tumor killing
Abstract Number: 5599
Session Category: Immunology
Session Title: T Cell Engagers 2 / Antibody-Drug Conjugates 1
Date: April 21, 2026
Time: 02:00 PM - 05:00 PM (Pacific Time)
           05:00 AM, April 22, 2026 - 08:00 AM, April 22, 2026 (Beijing Time)
Location: Poster Section 8

• Introduction: B7-H3 and PD-L1 are immune checkpoint molecules broadly overexpressed across multiple solid tumors and are associated with immune evasion and poor prognosis. Although PD-1/PD-L1-directed therapies have demonstrated clinical benefit, treatment resistance remains a significant challenge. B7-H3 is also emerging as a promising ADC target due to its broad tumor expression and rapid internalization. ATG-125 is a novel B7-H3 x PD-L1 bispecific ADC designed to combine direct tumor killing with immune activation by co-targeting two complementary tumor-associated pathways in a single molecule.
• Results: ATG-125 bound to both B7-H3 and PD-L1 with high specificity and nanomolar affinity and demonstrated robust antigen-dependent internalization in dual-positive tumor cells, enabling efficient intracellular payload release. The molecule induced tumor cell apoptosis, while its parental naked antibody blocked PD-1/PD-L1 interaction and elicited IL-2 and IFN-γ production in mixed lymphocyte reaction assays. ATG-125 also enhanced T-cell activation, as reflected by an increased ratio of CD69+/CD3+ T cells in co-cultures of tumor cells and human PBMCs. In vivo, ATG-125 demonstrated sustained antitumor activity in HCC827 xenograft models, increased tumor infiltration of CD4+ and CD8+ T cells in PBMC-humanized models, and inhibited tumor growth in a dose-dependent manner in MC38-hB7H3 syngeneic models, accompanied by elevated intratumoral CD8+ T-cell infiltration.
• Conclusion: ATG-125 demonstrated synergistic IO+ADC antitumor activity through a differentiated mechanism combining enhanced internalization for payload delivery with the potential to restore anti-tumor immunity. Its compelling preclinical profile supports further development for patients with solid tumors.

ATG-106 (CDH6 x CD3 TCE)
Title: ATG-106, a novel "2+1" format CDH6-targeted T-cell Engager (TCE), shows potent T cell dependent cytotoxicity and in vivo anti-tumor efficacy
Abstract Number: 1621
Session Category: Immunology
Session Title: T Cell Engagers 1
Date: April 20, 2026
Time: 09:00 AM - 12:00 PM (Pacific Time)
           00:00 AM, April 21, 2026 - 03:00 AM, April 21, 2026 (Beijing Time)
Location: Poster Section 10

• Introduction: CDH6 plays an important role in embryonic kidney development but has negligible expression in adult kidney tissue. Its overexpression in ovarian and renal cancers, together with limited normal tissue expression, makes CDH6 an attractive therapeutic target. However, T cell engagers in solid tumors have often been limited by insufficient efficacy and the risk of cytokine release syndrome. To address these challenges, Antengene developed ATG-106, a novel "2+1", sterically masked CDH6 x CD3 bispecific TCE designed to deliver potent antitumor activity with the potential for a reduced CRS risk profile.
• Results: ATG-106 exhibited reduced binding affinity to CD3+ cells before CDH6 crosslinking, while inducing approximately 100- to 400-fold more potent cytotoxicity against CDH6-positive tumor cells compared with a "1+1" CrossMab control TCE. The molecule demonstrated potent T cell-dependent cytotoxicity in ovarian and renal cancer models and showed low immunogenicity risk in vitro. In PBMC-humanized 786-O kidney cancer xenograft models, ATG-106 induced tumor shrinkage in all treated mice, with complete remissions observed in the 0.1 mg/kg and 0.3 mg/kg groups. ATG-106 also induced tumor shrinkage and complete remission in PBMC-humanized OVCAR-3 ovarian cancer models. Notably, pro-inflammatory cytokine levels remained very low in treated animals, suggesting low CRS risk. In non-human primate studies, the surrogate molecule ATG-106-RM was well tolerated at doses up to 10 mg/kg.
• Conclusion: ATG-106 demonstrated limited T cell binding in the absence of target cells, potent cytotoxicity against tumor cells, and encouraging in vivo efficacy in ovarian and kidney cancer models. Favorable safety findings with the surrogate molecule in non-human primates further support continued clinical development of ATG-106 as a CDH6-targeted TCE candidate.

ATG-112 (ALPPL2 x CD3 TCE)
Title: ATG-112, a novel ALPP/G x CD3 bispecific T cell engager, for the treatment of ALPP/G⁺ solid tumors
Abstract Number: 1620
Session Category: Immunology
Session Title: T Cell Engagers 1
Date: April 20, 2026
Time: 09:00 AM - 12:00 PM (Pacific Time)
           00:00 AM, April 21, 2026 - 03:00 AM, April 21, 2026 (Beijing Time)
Location: Poster Section 10

• Introduction: Placental alkaline phosphatase and related placental-like/germ-cell isoforms, including ALPPL2 and ALPG, are aberrantly expressed in a range of solid tumors while being largely absent from normal adult tissues except the placenta, making them highly promising tumor-selective immunotherapy targets. Antengene developed ATG-112, an ALPP/G x CD3 bispecific TCE based on the AnTenGager^® platform in a "2+1" format, featuring bivalent antigen binding to improve low-antigen tumor recognition and a sterically masked CD3 binding arm designed to restrict T-cell activation to the tumor microenvironment.
• Results: Tissue microarray IHC analysis showed that ALPP/G expression was restricted to placental tissue among normal organs and was not detected in other normal tissues, while frequent expression was observed in endometrial and ovarian cancers, with lower prevalence in bladder, gastric and pancreatic cancers. ATG-112 demonstrated high binding affinity to both ALPP/G-positive tumor cells and recombinant proteins, with EC50 and KD values in the sub-nanomolar range. It induced robust T cell-dependent cytotoxicity against target-positive cells with picomolar EC50 values, while in vitro cytokine-release assays showed minimal cytokine secretion from human PBMCs. In vitro studies also demonstrated that the spatial masking effect of ATG-112 is reversible. Immunogenicity assessment showed low immunogenic potential, and in vivo ATG-112 delivered potent tumor suppression across multiple dose levels in humanized mouse models, with low cytokine release and controllable CRS risk at efficacious doses. The program also demonstrated strong developability characteristics.
• Conclusion: ATG-112 demonstrated a compelling preclinical profile, with potent in vitro and in vivo antitumor activity and minimal cytokine release. These findings support the continued advancement of ATG-112 toward clinical development for solid tumors.

About Antengene
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) is a global, R&D-driven, commercial-stage biotech company focused on developing first-in-class/best-in-class therapeutics for diseases with significant unmet medical needs. Its pipeline spans from preclinical to commercial stages and includes several in-house discovered programs, including ATG-022 (CLDN18.2 ADC), ATG-037 (oral CD73 inhibitor), ATG-101 (PD-L1 x 4-1BB bispecific antibody), and ATG-125 (B7-H3 × PD-L1 bispecific ADC).

Antengene has also developed AnTenGager^®, a proprietary T cell engager 2.0 platform featuring "2+1" bivalent binding for low expressing targets, steric hindrance masking, and proprietary CD3 sequences with fast on/off kinetics to minimize cytokine release syndrome (CRS) and enhance efficacy. These characteristics support the platform's broad applicability across autoimmune disease, solid tumors and hematological malignancies, with programs targeting CD19 x CD3 (ATG-201 for B cell-related autoimmune diseases; partnered with UCB), CDH6 x CD3 (ATG-106 for ovarian cancer and kidney cancer), ALPPL2 x CD3 (ATG-112 for gynecological tumors, digestive system malignancies, bladder cancer and NSCLC), LY6G6D x CD3 (ATG-110 for microsatellite-stable colorectal cancer), GPRC5D x CD3 (ATG-021 for multiple myeloma), LILRB4 x CD3 (ATG-102 for acute myeloid leukemia and chronic myelomonocytic leukemia) and FLT3 x CD3 (ATG-107 for acute myeloid leukemia).

To date, Antengene has obtained 32 investigational new drug (IND) approvals in the U.S. and Asia, and obtained new drug application (NDA) approvals in 10 Asia Pacific markets. Its lead commercial asset, XPOVIO^® (selinexor), is approved in the Mainland of China, Taiwan China, Hong Kong China, Macau China, South Korea, Singapore, Malaysia, Thailand, Indonesia and Australia, and has been included in the national insurance schemes in five of these markets (Mainland of China, Taiwan China, Australia, South Korea and Singapore).

Forward-looking statements
The forward-looking statements made in this article relate only to the events or information as of the date on which the statements are made in this article. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. In this article, statements of, or references to, our intentions or those of any of our Directors or our Company are made as of the date of this article. Any of these intentions may alter in light of future development. For a further discussion of these and other factors that could cause future results to differ materially from any forward-looking statement, please see the other risks and uncertainties described in the Company's Annual Report for the year ended December 31, 2025, and the documents subsequently submitted to the Hong Kong Stock Exchange.

For more information, please contact:

Investor Contacts: 
Donald Lung
E-mail: donald.lung@antengene.com  

BD Contacts:
Ariel Guo
E-mail: ariel.guo@antengene.com 

RSV is a common virus that can cause severe respiratory illness in infants and young children, including lower respiratory tract infections (LRTIs) such as bronchiolitis and pneumonia. It is a leading cause of infant hospitalisation worldwide, with early-life infection linked to potential longer-term effects including recurrent wheeze or asthma, repeat hospital admissions and impaired lung health.

In England, a national maternal RSV vaccination programme was introduced on 1 September 2024, offering the Bivalent Prefusion F vaccine to pregnant women from 28 weeks' gestation.

To evaluate its impact on infant hospitalisations due to RSV-associated LRTI, researchers from the UK Health Security Agency (UKHSA) conducted a retrospective cohort study using linked national datasets, including NHS maternity records, immunisation data and hospital and laboratory data. The analysis included 289,399 infants born between 2 September 2024 and 24 March 2025, representing around 90% of births in England during this period.

Across the study population, 4,594 RSV-associated hospitalisations were recorded. Although infants born to unvaccinated mothers made up 55% of the total cohort, they accounted for 87.2% of hospitalisations.

In contrast, infants whose mothers were vaccinated at least 14 days before birth had a markedly lower risk of hospitalisation, with vaccine effectiveness estimated at 81.3%, relative to the unvaccinated group.

Lead author and UKHSA epidemiologist Matt Wilson commented, "As the largest study to date examining the impact of this vaccine on infant hospitalisation, these findings provide robust evidence that vaccination offers substantial protection against severe illness in young infants. We found a clear relationship between timing and protection, with effectiveness increasing as the interval between vaccination and birth lengthens, reaching close to 85% when vaccination occurs at least four weeks before delivery."

The study also investigated outcomes in preterm infants. Vaccine effectiveness was estimated at 69.4% in preterm infants, when allowing at least 14 days between vaccination and birth.  

"These findings are particularly important for preterm infants, who are among the most vulnerable to severe RSV infection," added Wilson. "With sufficient time between vaccination and birth, we saw good levels of protection in these babies."

Lunit's AACR 2026 presentations showed how AI-driven biomarkers can improve the efficiency of clinical workflows, uncover spatial features of the tumor microenvironment not captured by conventional methods, and enable integrated analysis to better support treatment decision-making.

SEOUL, South Korea, April 18, 2026 /PRNewswire/ -- Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, presented six studies at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place from April 17 to 22 in San Diego, California.

The presentations highlighted Lunit's continued advancements in AI-driven biomarker development, tumor microenvironment (TME) analysis, and real-world clinical applicability. Several studies were conducted in collaboration with global partners, including Agilent Technologies.

In a study conducted with Agilent Technologies and Ajou University Medical Center, researchers used Lunit SCOPE IO and uIHC to analyze over 25,000 non-small cell lung cancer (NSCLC) samples. The results showed that tumors with high c-MET expression exhibited a significant reduction in immune cell density within 30 μm of tumor cells (p<0.001), revealing a spatial immune exclusion pattern not captured by conventional analysis. These findings suggest a potential link between c-MET overexpression and immune evasion, supporting combination strategies involving MET-targeted therapy and immunotherapy.

Researchers also present findings from an exploratory analysis of the phase II MOUNTAINEER trial, demonstrating that AI- quantified HER2 expression is strongly associated with treatment response in patients with HER2-positive metastatic colorectal cancer treated with tucatinib plus trastuzumab. The overall objective response rate (ORR) was 43.4%, increasing to as high as 80% in patients with higher HER2 expression, indicating a clearer dose-dependent relationship. Tumor-Infiltrating Lymphocyte (TIL) density independently predicted progression-free survival. Notably, patients with low stromal TIL levels showed no response (ORR 0%) and a significantly higher risk of disease progression.

These findings highlight the increasing complexity of biomarker assessment, where both tumor characteristics and immune context need to be considered, underscoring the potential role of AI in supporting treatment decision-making.

In addition to these representative studies, Lunit presented additional research abstracts at AACR 2026, further demonstrating the breadth of its AI-powered oncology research. These include studies on

• AI-based analysis of tumor-infiltrating lymphocyte in NSCLC in collaboration with Dr. David Rimm's lab at Yale University School of Medicine
• AI-based target discovery for bi-specific antibodies
• Biomarker research in CD47-targeted therapies

"Our AACR presentations reflect how AI is increasingly translating into real-world clinical impact" said Brandon Suh, CEO of Lunit. "Across these studies, we demonstrate how AI-driven biomarkers can enhance precision, deepen our understanding of tumor biology and increasingly support treatment decision-making in clinical practice."

Visit Lunit at Booth #2248 during AACR 2026 to learn more about its latest research and AI-powered solutions in cancer diagnostics and therapeutics.

Lunit's featured presentations at AACR 2026 include:

[Poster #0011/11] Artificial intelligence-based spatial analysis of the local tumor microenvironment in relation to c-MET expression in non-small cell lung cancer
April 19, 2:00 PM - 5:00 PM, Section 1

[Poster #7735/26] HER2 expression and tumor-infiltrating lymphocytes predict response to tucatinib plus trastuzumab in HER2-positive metastatic colorectal cancer (MOUNTAINEER): Exploratory analysis of a multicenter, Phase II trial
April 22, 9:00 AM - 12:00 PM, Section 41

[Poster #4415/23] AI-powered analysis of millions of IHC images identifies 19 spatially highly co-expressed protein pairs to enable bispecific antibody development
April 21, 9:00 AM - 12:00 PM, Section 11

[Poster #0080/11] Quantitative assessment of tumor-infiltrating lymphocytes using AI in non-small cell lung cancer and association with immunotherapy response
April 19, 2:00 PM - 5:00 PM, Section 4

[Poster #4355/26] Cryo EM-based structural characterization of IMC-002, a next-generation anti-CD47 antibody with a unique binding site and biomarker candidates, supporting evidence of enhanced safety and efficacy
April 21, 9:00 AM - 12:00 PM, Section 9

About Lunit

Founded in 2013, Lunit (KRX: 328130) is a global leader on a mission to conquer cancer through AI. Our clinically validated solutions span medical imaging, breast health, and biomarker analysis—empowering earlier detection, smarter treatment decisions, and more precise outcomes across the cancer care continuum.

Lunit offers a comprehensive suite spanning risk prediction and early detection to precision oncology. Our FDA-cleared Lunit INSIGHT Breast Suite and breast health solutions support cancer screening in thousands of medical institutions worldwide, while the Lunit SCOPE platform is used in research partnership with global pharma and laboratory leaders for biomarker research, and companion diagnostic development.

Trusted by over 10,000 sites in more than 65 countries, Lunit combines deep medical expertise with continuously evolving datasets to deliver measurable impact—for patients, clinicians, and researchers alike. Headquartered in Seoul with global offices, Lunit is driving the worldwide fight against cancer. Learn more at lunit.io.

About Lunit SCOPE

Lunit SCOPE is a suite of AI-powered software that analyzes tissue slide images for digital pathology and AI biomarker development, aiming to optimize workflow and facilitate more accurate and predictive clinical data for clinicians and researchers. Lunit SCOPE platform offers multiple AI-powered tissue analysis products and assays that can streamline digital pathology workflow and diagnostics and enhance the drug development process. Lunit SCOPE IO analyzes the tumor microenvironment (TME) based on H&E analysis and provides AI-based predictive clinical outcome information. In addition, AI-driven Immunohistochemistry (IHC) slide analysis services are offered through products such as Lunit SCOPE PD-L1, Lunit SCOPE HER2, Lunit SCOPE ER/PR, and others.

As large models, reliable robotic hardware, and real-world data flywheels converge, embodied AI is rapidly evolving into a new production infrastructure. Building on the industry's shift from "showcasing capabilities" to "delivering results," AGIBOT's latest releases aim to accelerate this transition, from showcasing capabilities to delivering measurable outcomes across industrial, commercial, and service environments.

"Embodied intelligence is no longer a concept, it is becoming a new form of productive infrastructure," said Peng Zhihui, Co-founder, President and CTO of AGIBOT. "We are moving embodied intelligence from laboratory curiosity to production-line reality, enabling robots to truly integrate into human workflows and create measurable value across major scenarios."

Reliable Bodies as the Foundation of Embodied AI
AGIBOT unveiled 5 new robotic platforms designed to support diverse real-world scenarios, from entertainment and retail to industrial operations and field inspection.

AGIBOT A3: Silicon-based Stage Star
The AGIBOT A3 humanoid robot is a new generation of high-performance, highly customizable platforms designed for interactive environments. Standing 173 cm tall and weighing just 55 kg with elegant golden-ratio aesthetics, it utilizes lightweight magnesium, titanium, and TPU materials to achieve an industry-leading 0.218 kW/kg power-to-weight ratio. Equipped with 10-hour ultra-long endurance, 10-second battery swap, advanced UWB centimeter-level swarm positioning for synchronized 100-robot performances, shoulder tactile sensing, and 360° multi-array microphones, the A3 enables seamless multi-robot coordination at scale. Its enhanced interaction system with full-direction audio capture further makes it ideal for entertainment, education, and customer engagement applications.

AGIBOT G2 Air: Lightweight "Human-Machine Collaborative New Paradigm"
AGIBOT G2 Air is a compact, highly agile single-arm mobile manipulator designed for light-duty, human-in-the-loop operations. It features 7 DOF, a 3 kg payload, 750–800 mm reach, sub-800 mm width, and speeds of ≥1.5 m/s. Optimized for seamless human–robot collaboration, it improves efficiency and consistency while addressing the cost–quality challenges of manual work. Its responsiveness and rapid deployment make it well-suited for retail, hospitality, logistics, and structured industrial workflows.

AGIBOT G2 Air also unifies task execution and data collection into a single workflow. Unlike traditional approaches that separate manual operations from AI training, it enables real-time data capture during task execution. Built on a UMI-isomorphic layout, it ensures alignment between egocentric and real-machine data. With an "agile, swift, compact" design, it operates in sub-800 mm spaces with zero-radius turning, and supports a clear upgrade path from assisted operation to full autonomy, protecting investment as AI capabilities evolve.

OmniHand 3 Ultra-T：Flagship of the NEW Omni 3 Series
OmniHand 3 Ultra-T represents the next-generation upgrade of the OmniHand portfolio, delivering industry-leading, human-level dexterity. It features a 22+3 DOF tendon-driven system, a lightweight 500g design, and a 10:1 load-to-weight ratio. With full-hand 3D tactile sensing, an integrated palm camera, sub-0.3s response time, and a wide wrist range (55° pitch, 40° yaw), it enables precise manipulation across industrial assembly, domestic tasks, and multi-axis operations.

Alongside the flagship, two additional products expand the lineup: the industrial-grade OmniPicker 3 gripper, with 140N force, 1,000,000-cycle durability, and modular tactile sensing; and OmniHand 3 Lite, a ruggedized dexterous hand for high-impact environments. Together, the portfolio delivers both high performance and accessible solutions across diverse real-world applications.

D2 Max: The First All-Terrain Level 3 Autonomous Quadruped Robot
AGIBOT's next-generation flagship quadruped robot, the D2 Max, is the world's first all‑terrain Level 3 autonomous quadruped robot, defining a new standard for AGI‑driven autonomous operation. It delivers exceptional all‑terrain performance and reliability. Designed for mission-critical scenarios, the D2 Max excels in security patrol, industrial inspection, emergency rescue, logistics, agriculture, and education, transforming traditional quadruped robots from remote‑controlled tools into highly autonomous intelligent systems.

MEgo: Body-Free Data Collection System for Scalable Physical AI
MEgo is a next-generation body-free data collection system that redefines how physical AI data is generated. By removing reliance on robotic hardware, it introduces a human-centric, "capture-as-you-go" approach, enabling operators to collect high-quality multimodal data across real-world environments, from factories to retail and homes, with significantly lower cost and greater scalability.

The system combines MEgo Gripper and MEgo View to capture synchronized vision, motion, and tactile data with high precision, and is powered by the MEgo Engine platform for automated processing, reconstruction, and annotation. Together, they form a complete end-to-end pipeline, delivering ready-to-train datasets for embodied AI at scale.

Unveiling 8 Foundational AI Models Powering 3 Pillars of Embodied Intelligence
Alongside its robotic advancements, AGIBOT introduced eight foundational AI products organized under its "One Robotic Body, Three Intelligences" architecture, spanning Locomotion Intelligence, Manipulation Intelligence, and Interactive Intelligence. Together, these models form a unified Physical AI platform that integrates motion, task execution, and human interaction into a closed-loop system driven by data, simulation, and real-world deployment.

Locomotion Intelligence
Focused on enabling robots to move with human-like fluidity and adaptability in the physical world.

• BFM (Behavioral Foundation Model) teaches robots to imitate human movements instantly from a single demonstration or short video, delivering high stability even in noisy environments and dramatically accelerating new task deployment.
• GCFM (Generative Control Foundation Model) turns text, audio, or video inputs into natural, context-aware robot motions in real time, allowing dynamic improvisation and adaptation across entertainment and industrial scenarios.

Manipulation Intelligence
Focused on turning high-level understanding into reliable real-world task execution and productivity.

• AGIBOT WORLD 2026 is the open-source, production-grade real-world dataset collected from authentic industrial, logistics, home, hotel, and commercial scenarios, providing the high-quality data foundation for capable manipulation intelligence.
• GO-2 (ViLLA Embodied Foundation Model) bridges planning and execution with Action Chain-of-Thought, enabling consistent long-horizon task performance and achieving state-of-the-art results on major benchmarks.
• GE-2 (World Action Model) creates interactive virtual worlds for safe, high-speed strategy testing and continuous improvement.
• Genie Sim 3.0 is the one-stop simulation platform that uses natural language to instantly generate accurate digital twins of real environments for rapid training and near-perfect sim-to-real transfer.
• SOP (Real-World Distributed Online Learning System) allows deployed robot fleets to learn continuously from real operations, turning every task into model improvement and enabling exponential scaling.

Interactive Intelligence
Focused on natural, human-centered collaboration.

• WITA Omni is the industry's first robot-native end-to-end multimodal interaction model. It seamlessly fuses vision, audio, language, and action, enabling context-aware, emotionally intelligent responses with synchronized speech, gestures, and expressions, making robots intuitive partners in retail, hospitality, education, and daily life.

These eight models, tightly coupled with real-world data and simulation, form a closed-loop system that continuously evolves through deployment, moving embodied AI from isolated capabilities toward scalable, production-ready intelligence.

Full-Stack Architecture and Open Ecosystem for Scalable Deployment
Building on its "One Robotic Body, Three Intelligences" architecture, AGIBOT is extending its capabilities beyond models and hardware into a full-stack ecosystem designed to support large-scale deployment of embodied AI.

To accelerate adoption, AGIBOT continues to expand its open ecosystem through its AIMA (AI Machine Architecture) platform. This ecosystem integrates key development layers across embodied AI, including operating systems, interaction frameworks, development tools, and deployment platforms.

Core components of the AIMA ecosystem include:

• Link-U OS: Native operating system for embodied intelligence
• LinkSoul Platform: Persistent personality, memory, and long-term interaction engine
• LinkCraft Platform: No-code environment for motion and behavior creation
• Genie Studio: Full-stack development platform covering data collection, training, simulation, and deployment

Together, these platforms lower the barrier to entry for embodied AI development and enable partners across industries to build, customize, and scale applications more efficiently.

Advancing Real-World Deployment at Scale
AGIBOT emphasized that the inflection point for embodied AI lies not only in model breakthroughs, but in the ability to deploy systems reliably at scale within real-world workflows.

To support this transition, the company introduced a portfolio of production-ready solutions across key scenarios, including industrial handling, logistics sorting, retail services, security inspection, and commercial operations. These solutions are designed to integrate seamlessly into existing environments, enabling robots to deliver measurable productivity improvements.

With hundreds of robots already deployed across multiple projects and a rapidly expanding partner ecosystem, AGIBOT is advancing a new paradigm for the industry, shifting from delivering standalone robotic systems to providing outcome-driven solutions.

As embodied AI enters this next phase, AGIBOT's integrated approach positions it at the forefront of transforming intelligent machines into a scalable, real-world productive force.

For more information, please visit AGIBOT at AGIBOT.com and follow AGIBOT on:

https://www.facebook.com/AGIBOT.zhiyuan
https://x.com/AGIBOT_zhiyuan
https://www.instagram.com/AGIBOT_
https://www.tiktok.com/@agibot_
https://www.youtube.com/@AGIBOT-robot

About AGIBOT
AGIBOT is dedicated to driving innovation through the integration of AI and robotics, creating world-leading general-purpose embodied robot products and an application ecosystem. Built on the foundation of the robotic body and powered by the fusion of interaction, manipulation, and locomotion intelligence - "1 Robotic Body, 3 Intelligence" - AGIBOT is a leading robotics company in the industry to deliver a complete product portfolio and deploy across all major application scenarios. In March 2026, AGIBOT announced the rollout of its 10,000th robot, marking a major milestone in large-scale production and deployment.

Building on three years of rapid evolution, from R&D to mass production to commercialization, AGIBOT highlighted a fundamental industry transition: artificial intelligence is moving beyond digital cognition into real-world execution. As embodied systems begin to operate reliably in physical environments, the industry is entering a critical phase where scalable deployment and tangible productivity value are becoming achievable at scale. Against this backdrop, AGIBOT is positioning itself as a key architect of the emerging Physical AI ecosystem.

"The industry is moving from proving what robots can do, to proving what value they can consistently deliver at scale," said Edward Deng, Founder, Chairman and CEO of AGIBOT. "At AGIBOT, we focus on making embodied intelligence deployable, combining motion, interaction, and manipulation intelligence into one system that can operate under real-world constraints. Our goal is not just to build capable robotic machines, but to turn them into reliable units of productivity that can be scaled across industries."

A Full-Series Portfolio Built on a Unified Physical Intelligence Architecture
At APC 2026, AGIBOT unveiled its latest technological architecture at APC 2026, positioning itself as the only company to offer a full-series, full-scenario lineup spanning humanoids, wheeled platforms, and multi-form robots across different sizes and applications.

At the core of this portfolio is AGIBOT's "One Robotic Body with Three Intelligences" framework, an engineering-ready paradigm that integrates motion, interaction, and operation intelligence into a unified system. Within this architecture, the robotic body serves not only as the physical carrier of intelligence, but also as the critical interface to the real world, where perception, decision-making, and execution must operate under real physical constraints such as force, precision, timing, and safety. This tight coupling between intelligence and embodiment enables robots to move beyond isolated capabilities toward full-domain generalization in complex environments.

Supported by one of the most comprehensive full-stack technology systems in embodied AI, spanning both "brain" and "body", and reinforced by industry-leading mass production capabilities, AGIBOT continues to iterate its product lineup while systematically scaling deployment across increasingly complex real-world scenarios.

The XYZ Framework for Embodied Intelligence
At APC 2026, AGIBOT introduced a clear XYZ-curve framework to define the development trajectory of the embodied intelligence industry.

• The X curve (2022–2026) represents the development and early adoption stage, where foundational breakthroughs enabled robots to achieve human-like movement. This stage is characterized by a development-state data flywheel, rapid advances in motion intelligence, and the stabilization of robotic hardware for mass production.
• The Y curve (2026–2030) marks the deployment growth stage, where the focus shifts from capability validation to large-scale value creation. In this stage, productivity begins to approach human levels, driven by a deployment-state data flywheel, the scaling of interaction intelligence, and the scenario-based deployment of operation intelligence, leading to the emergence of embodied agents capable of executing real tasks.
• Looking ahead, the Z curve (2030 onward) represents the deployment and popularization stage, where intelligence evolves from quantitative accumulation to qualitative breakthroughs. Generalization capabilities expand significantly, collective intelligence emerges, and robots begin to surpass human productivity in selected domains.

With 2026 declared as "Deployment Year One," AGIBOT is formally transitioning the industry into the era of measurable productivity. This milestone is underscored by the company's announcement of the rollout of its 10,000th robot as of March 2026, reflecting both manufacturing scale and accelerating real-world adoption. Combined with rapid revenue growth, AGIBOT has established itself as one of the fastest-scaling embodied AI companies globally.

Seven Standardized Solutions Driving Real-World Adoption
To accelerate commercialization, AGIBOT introduced seven standardized productivity solutions targeting high-value industry scenarios: loading and unloading, industrial handling, logistics sorting, guidance and retail assistance, retail service stations, security patrol, and industrial & commercial cleaning. Each solution integrates hardware, AI models, and data systems into a unified, repeatable deployment package, enabling faster rollout cycles and lower integration complexity. Unlike traditional robotics deployments that rely heavily on customization, AGIBOT's approach emphasizes modularity, scalability, and measurable ROI.

Backed by real-world deployments across manufacturing, logistics, retail, and public infrastructure, these solutions have demonstrated quantifiable impact, from improved efficiency and precision to reduced labor costs and enhanced service capabilities. This solution-driven model marks a critical step in transitioning embodied AI from pilot projects to scalable productivity infrastructure.

Launching AIMA, A Full-Stack Open Architecture for Embodied AI
Reinforcing its role as an ecosystem builder, AGIBOT also announced the launch of AIMA (AI Machine Architecture), the industry's first complete open technology system for embodied intelligence. Designed as a "1+3+X" architecture, AIMA consists of a unified robot operating system (Link-U OS), three core development platforms - LinkCraft for motion creation, LinkSoul for interaction design, and Genie Studio for task development - and an extensible ecosystem layer supporting a wide range of applications. The "X" represents the AGIBOT Embodied Agent Framework, enabling deployment across commercial, industrial, and home scenarios, while supporting developers and ecosystem partners.

This full-stack architecture provides an end-to-end toolchain, from low-level system control to high-level application development, significantly reducing the complexity and cost of building embodied AI solutions. Through continuous open-sourcing and platform expansion, AGIBOT has already attracted a rapidly growing global community of developers and partners, laying the foundation for scalable ecosystem innovation.

Building a Global Ecosystem for the Next Phase of Productivity
Over the next five years, AGIBOT plans to invest more than RMB 2 billion to expand its ecosystem, working alongside leading universities, industry partners, and developers to build a globally competitive embodied AI infrastructure. AGIBOT also aims to support thousands of partners and cultivate a large-scale developer community, driving both technological innovation and commercial adoption. Looking toward 2030, AGIBOT envisions embodied intelligence reaching the stage of widespread adoption, unlocking trillion-scale market potential and enabling robots to become a fundamental layer of productivity across industries.

By aligning technology, ecosystem, and commercial deployment, AGIBOT aims to usher in a new era of embodied AI-driven productivity.

For more information, please visit AGIBOT at AGIBOT.com and follow AGIBOT on:

https://www.facebook.com/AGIBOT.zhiyuan
https://x.com/AGIBOT_zhiyuan
https://www.instagram.com/AGIBOT_
https://www.tiktok.com/@agibot_
https://www.youtube.com/@AGIBOT-robot

About AGIBOT
AGIBOT is dedicated to driving innovation through the integration of AI and robotics, creating world-leading general-purpose embodied robot products and an application ecosystem. Built on the foundation of the robotic body and powered by the fusion of interaction, manipulation, and locomotion intelligence - "1 Robotic Body, 3 Intelligence" - AGIBOT is a leading robotics company in the industry to deliver a complete product portfolio and deploy across all major application scenarios. In March 2026, AGIBOT announced the rollout of its 10,000th robot, marking a major milestone in large-scale production and deployment.

Kickstarting with DJ Charlie Tee in the French Alps, the campaign, titled Remote Raving Scenes, explores the power of electronic music to escape, unwind and intentionally reset

BONCOURT, Switzerland, April 18, 2026 /PRNewswire/ -- Today, Vuse, the no.1 global vape brand*, announces the launch of its new content series Remote Raving Scenes which explores the trend of remote raving, looking at how culture is shifting from passive entertainment to intentional participation and connection, allowing you to truly immerse in the moment.

Remote_Raving_Scenes

The first in the series, Unwind In the Mountains, in partnership with acclaimed DJ Charlie Tee, transports audiences to the breathtaking mountain location of Alpe D'huez in France during Tomorrowland Winter, providing a fresh perspective on how electronic music is adapting and thriving in new forms. Watch here.

From the anticipation and the instant community to, at times, the digital distance, remote raving creates a profound connection between music, nature, and personal freedom. The first of these short films from Vuse and Charlie explores how intentional travel, music and environment combine to create an epic moment of collective release. With content that covers her arrival in the Alps, her magnetic sets, and an exploration of why people travel to remote and unique places for music, Charlie brings to life why some events and DJ sets resonate more than others.

DJ Charlie Tee says "My journey to the Alps wasn't just about playing music; it was about discovering how travel and the right music can combine to create a set of truly exceptional moments where you can escape the everyday. It's these moments that help you reconnect, intentionally 'switch in' for yourself and immerse in a collective experience with like-minded people."

A recent report which explores the cultural evolution of how audiences are engaging with electronic music highlighted that whilst there has been a 36 per cent decline in UK nightclubs since March 2020, overall event programming has expanded by 10.5 per cent year-on-year. There has also been an 82 per cent growth in daytime events since 2022, expanding nearly three times faster than nighttime programming**. These statistics show a clear shift in the clubbing scene moving beyond traditional venues to embrace diverse, often more accessible, and unique experiences, with communities reclaiming their own version of how they escape whilst enjoying electronic music.

Immersive and different clubbing locations is not only of value to the audience, but also the DJs themselves. Speaking to a few up-and-coming DJs across Europe, Vuse found that the best off-grid settings are the ones you wouldn't usually associate with nightlife. One DJ from Austria said: "It's less about the crowd and more about the energy – that feeling when music takes over and transforms any space into something unforgettable."

From small gatherings in the mountains, to small sunset sessions by the sea, it's clear that the most incredible remote raving moments happen in the simplest, most unexpected places.

Creator and DJ Zoe London, commented: "I've been fortunate to play in some incredibly unique spaces - from DJing up a mountain in the highest club in Europe, in Val Thorens, to the unique environment of a disused station that used to be an underground skatepark in London. I love the idea of performing in an old school factory which still has its artefacts, centring the DJ set within it to create a truly unique moment." 

Tomorrowland, one of the world's most iconic electronic music festivals, highlights the power of location in creating unforgettable moments.

The Vuse Remote Raving Scenes series features exclusive sets from a varied line up of globally renowned DJs exploring different remote raving locations, kicking off with DJ Charlie Tee. The first episode will launch on 17^th April 2026 with the others rolling out over 2026.

For more information please visit: @vuse.worldwide or http://www.youtube.com/@Vuse_worldwide

Notes to Editors

*Based on Vuse estimated value share of vapour pods and pre-filled devices from Recommended Retail Price in total measured retail in key vapour markets: USA, Canada, France, UK, Germany, Poland and Spain as of September 2025.

**Statistics taken from NTIA's The Fourth UK Electronic Music Industry Report - NTIA

About BAT

BAT is a leading global multi-category consumer goods business. Underpinned by world-leading science and research and development, our purpose is to create A Better Tomorrow™ by Building a Smokeless World.

Central to achieving this is the concept of Tobacco Harm Reduction (THR) – the switching of smokers, who would otherwise continue to smoke, from risky forms of combustible tobacco products like cigarettes, to lower risk profile smokeless tobacco and nicotine products. This is outlined further in Omni™, an evidence-based manifesto for change, which captures BAT's commitment and progress on THR.

BAT employs more than 48,000 people and, in 2024, generated revenue of £25.9bn, with an adjusted profit from operations of £11.9bn.

BAT's aim is to have 50 million adult consumers of its smokeless products by 2030 and generate 50% of its revenue from these products by 2035. With 30.5 million current users – including vapour brand Vuse; heated product brand glo; and modern oral (nicotine pouch) brand Velo – BAT's new category revenues have climbed to £3.4bn in 2024, with strong progress in profitability. 

BAT continues to strive towards reducing its use of virgin raw materials, enhancing the communities in which it operates and working towards net zero across its value chain by 2050. BAT received a "Triple-A" rating from CDP for its 2024 disclosures on Climate Change, Water Security and Forests; and was recently named a Financial Times Climate Leader for the fifth year running.

Among other items, shareholders will be asked to vote on the proposed appointment of Mr Robert Jan van de Kraats as Executive Director of OCI N.V. for a term of one year. The proposal follows the previously announced planned transition of Mr Nassef Sawiris from his role as Executive Chair of OCI N.V. to a non-executive director position at the conclusion of the AGM.

Further information on the proposed appointment, including remuneration arrangements, is set out in the AGM explanatory notes, which are available together with the AGM agenda and related materials at www.oci-global.com.

This press release contains information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

About OCI Global

Learn more about OCI at www.oci-global.com. You can also follow OCI on LinkedIn.

LAS VEGAS, April 18, 2026 /PRNewswire/ -- DJI, the world's leader in creative camera technology, will showcase how innovation and creativity have transformed storytelling at the 2026 NAB Show. With the company's award-winning Ronin and Osmo product lines on full display, the company is demonstrating its commitment to empowering filmmakers and creators everywhere. From April 19-22, creators of all levels can experience first-hand the company's best-in-class integrated ecosystem of cameras, stabilizers, gimbals, microphones, and power solutions. Conference attendees can also participate in hands-on demos and interactive workshops at the DJI booth.

Explore Ronin: Award-Winning Filmmaking Technology

From full-length feature films to broadcast television productions, the Ronin ecosystem of cinematic cameras and stabilizer systems has become industry standards for powerful and versatile storytelling. Attendees can get hands-on experience with the Oscar- and Emmy-award-winning Ronin series through the booth's professional-grade film set. It will feature a car outfitted with DJI's diverse creative car shooting solutions, including:

• Ronin 2 Car Rigging Solution
• Ronin 4D Car Exterior Suction Cup Mount Solution
• Ronin 4D Flex Car Interior Shooting Solution
• RS 4 Pro Car Exterior Suction Cup Mount Solution

NAB Show attendees can experience the newly-launched RS 5. This all-new lightweight commercial camera stabilizer features the next-gen RS Intelligent Tracking Module that can keep people, vehicles, pets, and other objects in frame from up to 10 meters away. Other Ronin products to be showcased include the groundbreaking DJI Ronin 4D, Ronin 2, Transmission, SDR Transmission, Focus Pro, RS 4 Pro, RS 4, and RS 4 Mini. 

Discover Osmo: Making Storytelling Possible for Everyone

Creators of all levels now have access to the professional-level tools. Designed to be versatile and intuitive, the Osmo product ecosystem features best-in-class cameras, smartphone gimbals, and microphones for every kind of storyteller. Attendees can try out the newest flagship Osmo cameras, including DJI's first 360° camera, Osmo 360, DJI's lightweight wearable camera, Osmo Nano, and the all-in-one flagship action camera, Osmo Action 6. Attendees can also experience the latest smartphone gimbals and audio recording solutions, Osmo Mobile 8 and DJI Mic 3.

Experience DJI Power: Keep the Lights On and Cameras Rolling 

Filmmakers and creators can depend on DJI's collection of portable power stations for reliable power for any film set. Boasting powerful fast-charging capabilities with up to 3000W of output power and ultra-quiet 26dB operations, DJI Power products offer an excellent solution for improving production efficiency and workflows. Attendees can test the charging limits of the DJI Power 2000, Power 1000 v2, DJI Power 500, DJI Power Expansion Battery 2000, and DJI Power Super Fast Car Chargers.

Learn, Create, and Share

To foster creativity and skill development, DJI will host a series of workshops with filmmaking experts and talented content creators. Blake Ridder, Brandon Li, and trystane will share their expert insights into how DJI's suite of creative tools bolsters visual storytelling. These workshops are open to all NAB visitors.  

See You at NAB Show

NAB Show will open its doors at the Las Vegas Convention Center from April 19-22, 2026. Visitors can find DJI in the Central Hall, Booth Number C6719.

About DJI
Since 2006, DJI has led the world with civilian drone innovations that have empowered individuals to take flight for the first time, visionaries to turn their imagination into reality, and professionals to transform their work entirely. Today, DJI serves to build a better world by continuously promoting human advancement. With a solution-oriented mindset and genuine curiosity, DJI has expanded its ambitions into areas such as cycling, renewable energy, agriculture, public safety, surveying and mapping, and infrastructure inspection. In every application, DJI products deliver experiences that add value to lives around the world in more profound ways than ever before. 

For more information, visit our:
DJI Ronin Website: pro.dji.com
DJI Ronin Instagram: instagram.com/dji_ronin
DJI Ronin YouTube: youtube.com/@DJI_Ronin
DJI Ronin Facebook: facebook.com/DJIRoninOfficial

Please also visit our official DJI channels:
Website: dji.com
Online Store: store.dji.com
Facebook: facebook.com/DJI
Instagram: instagram.com/DJIGlobal
X: x.com/DJIGlobal    
LinkedIn: linkedin.com/company/dji
Subscribe to our YouTube Channel: youtube.com/DJI 

Since the appointment of the Enterprise Chamber–appointed directors in January 2026 (the "EC Directors"), the Company has continued to support their work as non-executive members of OCI's Board. This has included their familiarisation with the Company, its governance framework, and matters relevant to the proposed transaction with Orascom Construction ("OC").

The EC Directors are participating fully in the work of the Board alongside the other Board members. Their role, as set out by the Enterprise Chamber, is to see to it that the Board fulfils its obligations towards OCI and OCI's stakeholders, including its minority shareholders, with the preparation of the proposed transaction with Orascom Construction or any other transaction with Orascom Construction. In this context, the EC Directors have access to management, all relevant information, and external advisers, and have appointed their own external legal and financial advisers to support their work. No outcome has been pre-judged, and the EC Directors' review and deliberations are ongoing.

Consistent with their mandate and the ongoing Enterprise Chamber proceedings, the EC Directors are maintaining a neutral and independent position in relation to all matters falling outside the scope of their special mandate, while participating in the Board's meetings in accordance with their role as non-executive directors.

The Company expects to provide a further update on process once the current phase of review has been completed and when it is appropriate to do so, taking into account the input of the EC Directors, the Board's decision–making and the ongoing Enterprise Chamber proceedings. In this regard, it is noted that the long stop date for the proposed transaction with OC is 30 June 2026, with either party having the option to extend such date to year-end. Any material developments will be communicated through appropriate public disclosures, in line with applicable disclosure obligations and the principle of equal treatment of shareholders.

If the proposed transaction does not proceed, it would be for the Board to determine the other strategic options available to the Company and to evaluate what would be in the best interests of the Company and all its shareholders. Such options could include a multi–year wind–down of the remaining business or the evaluation of alternative strategic avenues, together with associated capital allocation decisions. At this stage, it would be premature to comment on any outcomes, conclusions, or other substantive matters beyond what has already been disclosed.

In parallel, the Company has continued to execute announced divestments and to manage its remaining assets, liabilities, and liquidity in the ordinary course of business. Throughout the strategic review, the Board has a fiduciary duty to consider any credible approach relating to OCI and to evaluate such approaches in accordance with its duties to the Company and all shareholders.

About OCI Global

Learn more about OCI at www.oci-global.com. You can also follow OCI on LinkedIn.

TAIPEI, April 17, 2026 /PRNewswire/ -- Exein, a global leader in embedded runtime cybersecurity, today announced the opening of its APAC headquarters and Taipei office in Taiwan. The new hub will serve as a regional operations and technology base, working closely with Taiwanese and APAC partners to accelerate the adoption of runtime cybersecurity across the IoT ecosystem and export new global standards.

As international regulations such as the EU Cyber Resilience Act (CRA) evolve, device-level security has become both a regulatory requirement and a central industry priority. Leveraging Taiwan's leading position in the global semiconductor and electronics manufacturing supply chain, Exein is advancing the development of runtime cybersecurity technologies in IoT security ecosystem. By embedding AI-driven protection directly into devices, manufacturers can meet "security by design" requirements and gain access to global markets with greater confidence.

With the number of connected devices expected to exceed 25 billion by 2030, the attack surface continues to expand, with a significant portion of vulnerabilities linked to IoT endpoints. Exein addresses this challenge through AI-driven runtime protection embedded at the firmware level, enabling real-time detection and response to threats while maintaining performance impact.

The APAC region contributes nearly 50% of Exein's global revenue and has seen growth in 2025. Through strategic partnerships with MediaTek and ASPEED, Exein is expanding its footprint from IoT into data center infrastructure, integrating security capabilities into both edge devices and server platforms.

Gianni Cuozzo, Founder and CEO of Exein, said: "Expanding into APAC marks a key milestone in our global growth. Taiwan sits at the heart of the global technology supply chain, and establishing a presence here allows us to work more closely with partners shaping the next generation of connected devices. As IoT continues to grow, cybersecurity must evolve as a foundational capability. Our ambition is to make runtime cybersecurity a global standard."

Caesar Chuang, VP of Asia Pacific & Japan at Exein, added: "For manufacturers in Taiwan and across APAC, meeting regulations such as the CRA is becoming essential for entering global markets. By embedding security directly into devices, Exein helps companies meet compliance requirements from the earliest stages of product design. At the same time, we are building a strong regional ecosystem with partners such as MediaTek and ASPEED to make runtime cybersecurity a standard capability across the supply chain."

Exein Marketing Director, APAC
Cheryl Yen
cheryl@exein.io

According to research published by Multidisciplinary Digital Publishing Institute (MDPI), 48% of visitors attend food festivals more than twice, suggesting these events are becoming a recurring lifestyle activity. With the increasing scale and frequency of such events, ensuring food-safety handling practices becomes increasingly important.

Beyond that, the rising concern over food packaging containing unsustainable materials and harmful chemicals highlights the need for safer packaging solutions to protect consumers, especially at large-scale food festivals.

To address these challenges, the government has mandated Thai Industrial Standards (TIS) to ensure product safety, quality, and environmental protection specially for certain paper-based food contact materials, with stricter requirements expected to take effect in 2026.

These standards set requirements to ensure packaging materials are suitable for direct food contact and free from harmful substances. As a global pulp and paper company, APP Group supports Thailand's efforts to strengthen standards for food contact packaging and promote responsible packaging solutions.

"As the government strengthens food packaging regulations, we see this as a positive step toward improving food safety and sustainability. For food vendors and SMEs, access to reliable food-grade packaging is becoming essential and we are committed to supporting this transition through our sustainable packaging solutions," Kin Keung Christopher Wong, SVP & Global BU Head Industrial White, APP Group.

APP Group's Foopak packaging exceeds TIS chemical standards, with ISEGA and Intertek certifying it free of detectable lead, cadmium, and mercury. Made from 100% certified virgin pulp, it offers superior strength and eliminates the contamination risks associated with recycled materials, ensuring premium safety for direct food contact.

About APP Group

APP is a leading Indonesia-based pulp, paper, and forestry company supplying tissue, packaging, and paper products to more than 150 countries. Operating in Indonesia and China, APP integrates responsible sourcing and sustainability into its business strategy through its Sustainability Roadmap Vision 2030. The company also introduced Regenesis, its platform to advance long-term environmental and social commitments.

  Demonstrates rugged laptops, tablets, and AI solutions designed for vehicle inspections, end-of-lease evaluations, and remarketing

IRVINE, Calif., April 17, 2026 /PRNewswire/ -- Getac Technology Corporation (Getac), a leading provider of rugged computing and mobile video solutions and a manufacturer with advanced in-house capabilities, today announced it will participate in ETI ToolTech 2026, April 20–23 in Palm Harbor, Florida.

ETI ToolTech, hosted by the Equipment and Tool Institute (ETI), brings together tool and equipment suppliers, original equipment manufacturers (OEMs), and other vendors for education, networking, and one-on-one meetings. At the conference, Getac will showcase its rugged devices and AI-powered solutions directly to OEMs and industry partners, highlighting real-world applications in vehicle inspections, fleet management, and remarketing.

At the event, Getac will also spotlight its newly released V120 fully rugged convertible laptop and F120 fully rugged tablet, alongside its AI-powered vehicle inspection system, developed by a valued partner, Tchek, and optimized for use on Getac rugged devices.

This integrated solution supports a range of automotive workflows, including:

• Smart Repairs & Upsells: Identifying service needs with precision
• End-of-Lease & used car Evaluations: Accelerating the transition from vehicle return to remarketing
• Fleet Management: Improving consistency and speed of vehicle assessments and audits for brand protection and safety

The AI inspection system delivers measurable business impact, including reducing inspection time by up to one-third, achieving up to 95% accuracy in damage detection, and delivering a projected 120% return on investment within 12 months. These capabilities help automotive organizations improve efficiency, reduce manual effort, and drive more informed decision-making.

"Getac and Tchek share a common vision: delivering a field-ready solution that helps organizations modernize inspections and improve operational performance," said Anton Fert, Co-founder and CEO of Tcheck. "By combining Getac's purpose-built, edge-ready rugged ecosystem with Tchek's AI inspection capabilities, we are enabling customers to improve inspection quality, accelerate decision-making, and realize measurable outcomes in their daily operations."

"The automotive industry is at a turning point where rugged hardware and intelligent software must work together to drive real value through automation, efficiency savings and upselling opportunities," said Russell Younghusband, Global Automotive Director for Getac. "At ETI ToolTech, we're demonstrating how our AI-powered inspection system, combined with our V120 and F120 devices, helps organizations streamline inspections while improving accuracy and delivering measurable ROI."

For more information, visit www.getac.com

About Getac  

Getac Technology Corporation is a global leader in AI-capable rugged mobile technology and intelligent video solutions, including laptops, tablets, software, body-worn cameras, in-car video systems, digital evidence management, and enterprise video analytics solutions. Getac's  solutions and services are designed to enable extraordinary experiences for frontline workers in challenging environments. Today, Getac serves customers in over 100 countries spanning defense, public safety, ambulance, fire & rescue, utilities, automotive, natural resources, manufacturing, transport, and logistics. Getac was recently recognized as one of Newsweek's "World's Most Trustworthy Companies" for 2024. For more information, visit:  https://www.getac.com. Participate in the Getac Industry blog or follow the company on LinkedIn and YouTube.   

Getac and Getac logo are trademarks of Getac Holdings Corporation or its affiliates. Other brands or trademarks are the property of their respective owners. ©2026 Getac Technology Corporation.  

GAC Group President Xia Xianqing stated: "Our commitment remains unchanged: to root ourselves in technology, put our users first, and build a resilient GAC. We are determined to bring users a reliable intelligent mobility life with leading experience."

Five Core Technologies at a Glance

ADiMOTION Power is GAC's all-new power technology brand, comprising ADiMOTION Range Extension, ADiMOTION PHEV, and ADiMOTION HEV+, providing users with full-scenario power solutions. The ADiMOTION PHEV, certified by China Automotive Technology and Research Center as a "High-Quality Hybrid," drives B-class MPV fuel consumption into the 3-liter era. The ADiMOTION HEV+ features an industry-first 5.4kWh high-rate safety battery, propelling fuel hybrid technology into the 2.0 era.

Starship Body adopts an industry-first "Embedded Frame + Multi-Ring Cage" design, integrating the advantages of monocoque and body-on-frame bodies. With a torsional stiffness of 38,000N•m/° and 5-ton towing capacity, it delivers both off-road toughness and comfortable daily commuting.

ADiGO Intelligence features a Cloud-Edge Integrated Architecture with three AI engines — perception, multi-agent collaboration, and emotional expression — evolving the smart cockpit from reactive to proactively understanding users' needs.

X-SOUL Architecture 4.0 serves as the vehicle's digital foundation, achieving an industry-first six-domain fusion of intelligent driving, cockpit, powertrain, chassis, body, and connectivity. Full-vehicle OTA upgrades are completed in as fast as 8 minutes, ranking first in the industry.

In the Chip Ecosystem, GAC has completed joint development of nearly 400 chips with 105 ecological partners. The HYPTEC GT Climbing Edition — China's first intelligent NEV with 100% domestic chip design — will be launched soon. GAC also announced it will open all chip achievements to the entire industry, empowering rail transit, low-altitude economy, and embodied intelligence sectors.

Built on technology, GAC continues to forge ahead, contributing its strength to China's march toward becoming a global automotive powerhouse.

For further information about GAC, please visit: https://www.gacgroup.com/en or follow us on social.

As more consumers embrace road travel, van life, and off-grid exploration, the need for efficient, flexible, and durable cooling solutions has grown significantly. BougeRV's latest lineup meets that demand with two distinct offerings: a high-capacity, tech-enabled system and a compact, grab-and-go unit.

CRD2 V2.0: Dual-Zone, Smart-Controlled Cooling for Extended Trips

Engineered for longer journeys and demanding environments, the CRD2 V2.0 is a next-generation portable fridge/freezer that combines capacity, control, and durability.

Key features include:

• Independent Dual-Zone Cooling: Customize each compartment separately with temperatures ranging from -4°F to 68°F, allowing users to freeze, refrigerate, or turn off zones as needed
• Multiple Capacities: Available in 43QT, 52QT, and 61QT, providing ample space for family trips, group camping, or extended travel
• Powerful Cooling Performance: Capable of reaching 0°F even in ambient temperatures up to 90°F, ensuring reliable performance in hot climates
• Extended Runtime with Optional Battery: When paired with BougeRV's 240Wh LiFePO4 battery (sold separately), the unit delivers up to 20 hours of cooling (depending on size and conditions)
• Multi-Power Compatibility: Operates via AC (100–240V), DC (12/24V), and solar panels (battery required), offering seamless integration into off-grid setups
• Smart App Control: Monitor and adjust temperature remotely through the BougeRV mobile app for added convenience
• Whisper-Quiet Operation: Runs at ≤35dB, making it suitable for overnight use in vans, RVs, or tents
• Portable, Rugged Design: Built with integrated wheels and handles for easy transport across campsites or worksites

CRH20: Compact, Fast-Cooling Convenience for Everyday Use

Designed for mobility and simplicity, the CRH20 Portable Fridge offers a compact yet powerful cooling solution ideal for shorter trips and daily use.

Key features include:

• Compact, Space-Saving Design: Easy to fit in cars, trucks, or small camping setups without sacrificing functionality
• Rapid Cooling Performance: Quickly cool down to 0°F even in ambient temperatures as high as 90°F
• Extended Runtime with Optional Battery: Power for up to 30 hours with optional 240Wh LiFePO4 battery
• Simple, Intuitive Controls: Streamlined interface for easy temperature adjustment on the go
• Vehicle-Ready Power: Compatible with AC (100–240V), DC (12/24V), and solar panels (battery required) - making it ideal for road trips, commuting, and tailgating
• Lightweight & Portable: Designed for easy transport, making it a convenient option for day trips, picnics, and outdoor events

Built for the Modern Outdoor Lifestyle

Together, the CRD2 V2.0 and CRH20 reflect BougeRV's commitment to bringing home-level convenience into outdoor environments. Whether users need a high-capacity, fully customizable cooling system or a compact, everyday fridge, BougeRV offers solutions tailored to a wide range of use cases.

"These products are designed to meet people where they are—whether that's a multi-day off-grid expedition or a simple day at the beach," said Jason, a BougeRV spokesperson. "Our goal is to make outdoor living more comfortable, more flexible, and more accessible."

Availability

The BougeRV CRD2 V2.0 and CRH20 Portable Fridges will be available starting mid-April via BougeRV's official website and Amazon storefronts across the U.S., Europe, and Canada.

About BougeRV

BougeRV is dedicated to empowering outdoor adventurers with reliable, portable, and high-performance appliances. Through a thoughtfully designed ecosystem of outdoor appliances, batteries, and solar solutions, BougeRV helps people go further, stay longer, and live better — wherever the journey leads.

At SXSW official panel, TapNow CEO Jessie Qin introduced the first "agentic canvas" for filmmaking — a real-time, always-on creative partner that brings a Cursor-like experience into video production.

Instead of relying on fragmented tools and pipelines, creators can now ideate, generate, and iterate within a single continuous system——TapNow AI.

What was introduced at SXSW didn't remain a concept — it was immediately put into practice by filmmakers at Soulscape.

At Soulscape, the global AI cinema summit and hackathon co-hosted by TapNow AI, powering a dedicated AIGC filmmaking unit under its TapTV Arena. The event brought together thousands of Hollywood filmmakers, digital artists, and industry professionals working directly with AI as part of their creative process.

This wasn't a showcase — it was filmmakers already working this way.

In the final 48-hour AIGC Hackathon, participants produced a slate of short films with clear narrative structure and visual coherence. Notably, the winning project of the competition was created using TapNow.

"This signals a broader shift: AI is beginning to enter the actual workflows of professional creators, rather than remaining on the periphery as an experimental tool," said Klaus He, co-founder of TapNow at Soulscape.

Projects like "Before Me," completed within 48 hours, and "Glasswork," recognized for its emotional depth and nuanced performances, point toward a new production model — one where individual creators can deliver fully realized work without traditional constraints.

As this model begins to spread, a new creative ecosystem is starting to take shape — one where AI-native storytelling is no longer experimental, but scalable.

TapNow has recently launched "10,000 Parallel Universes," a global initiative inviting creators to build original story worlds from the ground up. Backed by over $1 million in funding, each project begins as a trailer, but is designed to evolve into a larger narrative universe.

The first generation of AI-native story IP is already emerging.

The question is no longer whether AI can make films.

 It's whether you join now — or catch up later.

SHANGHAI, April 17, 2026 /PRNewswire/ -- Shanghai Electric (SEHK: 02727, SSE: 601727) announced its 2025 performance results, reporting revenue of RMB 126.68 billion (USD 18.58 billion), marking a 9.03% year-on-year increase. The net profit attributable to shareholders of the listed company reached RMB 1.206 billion (USD 176.92 million), a surge of 60.37% year-on-year. The total value of new orders received throughout the year amounted to RMB 172.81 billion (USD 25.35 billion), up 12.50% year-on-year, hitting a record high.

At the annual results briefing held on April 2 in Hong Kong, Shanghai Electric presented the company's 2025 performance and key financial data, while engaging with a wide range of institutional investors and analysts on business developments and future plans. The company delivered solid performance across core operating metrics in 2025, with notable improvements in overall business quality, driven by breakthroughs in new orders, technological innovation, and segment synergy.

Strong growth in profitability, new orders, and segment revenue

In 2025, Shanghai Electric achieved critical breakthroughs in emerging sectors, accelerated the execution and deployment of independent innovations in high-end manufacturing, and continued to deepen its global market presence.

The group's total operating profit reached RMB 5.02 billion (USD 736.73 million), up 34.28% year-on-year. Basic earnings per share stood at RMB 0.078, a significant increase of 62.50%.

The energy equipment segment generated revenue of RMB 75.02 billion (USD 11.01 billion), up 21.48% year-on-year, continuing to consolidate its industry leadership position.

Significant growth was achieved in the high-growth business sectors:

• Wind power equipment orders reached RMB 22.966 billion (+32.18%, USD 3.37 billion);
• Nuclear power equipment orders hit RMB 9.888 billion (+25.37%, USD 1.45 billion);
• Gas power generation equipment orders amounted to RMB 3.095 billion (+33.35%, USD 454.04 million);
• Power station service orders came in at RMB 7.312 billion (+45.28%, USD 1.07 billion).

Strengthened innovation capabilities and emerging sector breakthroughs

Shanghai Electric has achieved significant technological breakthroughs in new areas, including green methanol, green hydrogen, energy storage, and superconducting power, steadily improving its level of technological independence.

In high-end manufacturing, self-developed innovative products such as humanoid robots, industrial machine tools, and precision bearings are accelerating market application, further strengthening the company's core capabilities in this sector.

With research and development expenses reaching RMB 6.164 billion (USD 904.26 million) in 2025, Shanghai Electric's sustained high investment in R&D continues to underpin technological innovation and product upgrades.

Advancing industrial optimization and global market presence

In response to investor inquiries regarding its robotics deployment, aviation equipment business development, nuclear power equipment exports, coal-fired power tender outlook, and gas turbine exports, Shanghai Electric reaffirmed its commitment to further strengthening its position in energy equipment, enhancing the operational efficiency of industrial equipment, and expanding its global integrated service capabilities.

• Traditional energy: to strengthen grid regulation capabilities and advance low-carbon upgrades, while accelerating the engineering deployment of nuclear power and nuclear fusion technologies.
• High-end manufacturing: to scale up the development of robotics, aerospace equipment, and advanced machine tools, with a focus on achieving breakthroughs in key core technologies.
• Overseas growth: to deepen its presence in overseas markets while enhancing its capabilities across desalination, power transmission and distribution, and energy equipment.

Executing 2026 priorities through innovation and digital transformation

In 2026, Shanghai Electric will continue to enhance core competitiveness with technological innovation as the primary engine, digital transformation as the main strategic direction, and green development as the foundation, to pursue high-end upgrades in traditional industries, scale up strategic emerging sectors, and make forward-looking moves in future industries.

"The Artist 16 3rd strikes the perfect balance between portability and creative space, allowing creators to capture and bring their ideas to life whenever inspiration strikes," said Brian Huang, Brand Director at XPPen. "With innovative industrial design language X-Dial shortcut and the brand-new X4 Smart Chip Stylus with 16K pressure levels, every creative session becomes intuitive and enjoyable, empowering users to unleash their creativity anytime, anywhere."

Golden Size Meets dual X-Dial + 8 Shortcut Keys

The 15.4-inch display features a 16:9 golden aspect ratio, balancing a roomy canvas with on-the-go convenience. Dual X-Dial and eight customizable shortcut keys put essential commands like zoom, brush adjustment, undo, and copy at your fingertips – no menu digging. The full-featured USB-C cable eliminates clutter with a single connection, a tidy creative setup anywhere.

X4 Smart Chip Stylus with Magnetic Snap

Upgraded X4 Smart Chip Stylus offers 16384 pressure levels, a 2g initial activation force, and a 50% shorter response time of just 30ms. It snaps securely to the top of the display via magnets – making storage and carrying effortless. The bullet-shaped tip enhances stability, while a new sensor solution reduces tip travel distance to just 0.3 mm, significantly reducing ink lag during the creative process.

Paper-Like Glass, True-to-Life Colors

AG+AF nano-etched glass resists glare and fingerprints, restoring a natural paper-like drawing experience. The Full HD 1920×1080 resolution delivers crisp details, supporting 16.7 million colors. It covers 99% sRGB with ΔE < 1.5 color accuracy, plus 98% Adobe RGB and 97% Display P3. DC dimming technology automatically adjusts brightness to ambient light conditions, reducing visual fatigue during extended creative sessions.

Pricing and Availability

The Artist 16 3rd is available as of April 17, 2026, with an early bird price of $319.99 (pricing and availability may vary by region). For more information, please visit: https://www.xp-pen.com/product/artist-16-3rd.html

FRANKFURT, Germany, April 17, 2026 /PRNewswire/ -- Bambu Lab launched the X2D this week — its next-generation flagship 3D printer with dual-extrusion, available starting at $649.

Bambu Lab introduces the X2D - a new 3D printer designed for people who want to create, not troubleshoot technical issues. It's a device that operates like any household device, yet prints like a professional production studio.

For years, 3D printing was the domain of enthusiasts willing to spend hours on calibration and experimenting with settings. Bambu Lab changed that in 2022 with the launch of the X1 series, which proved for the first time that a 3D printer could simply work - without specialized knowledge, without trial and error, straight out of the box. The X2D takes this a step further.

The most important change is how the X2D manages itself. It automatically calibrates before every print, monitors the process through dozens of sensors, and compensates in real time for any deviation from expected parameters. A print either succeeds - or the machine stops before anything goes wrong. All of this happens in the background: the user selects a model, clicks print, and returns to a finished object.

The X2D prints using two nozzles. In practice, this means that supports - temporary structures required for complex geometries - can be removed without effort. Instead of sanding and scraping after printing, the finished object is truly ready. For users creating home decor, decorative elements, jewelry, toys, or fashion accessories, the difference is immediate and noticeable.

The print chamber is enclosed and actively temperature-controlled, while a triple-stage air filtration system captures particles and absorbs odors. The X2D can comfortably be placed in a living room, studio, or office.

The X2D is part of the broader Bambu Lab ecosystem - The Bambu Experience

Buying the X2D is not just buying a printer. It is buying into an environment where hardware, software, materials and community are designed as a single system - not assembled from parts.

Bambu Studio, Bambu Handy, MakerWorld, Maker's Supply, Maker's Lab and the designer crowdfunding program are not add-ons. They are the context in which the printer operates. Filaments are profiled against specific hardware. Models come with validated print settings. Components are standardized to fit printed designs. The distance between an idea and a finished object keeps shrinking - not because the printer got faster, but because every layer of friction between the user and the result has been deliberately removed.

This is what Bambu Lab has been building since 2022, and what the X2D inherits: a product that is complete out of the box, and an ecosystem that grows more useful the longer you are inside it.

3D printing is no longer a hobby for the patient. The X2D is a tool for anyone who wants to create physical objects - without technical barriers and without compromising on quality.

The X2D is available starting at $649 / €629. The Combo version, including a multi-material feeding system, starts at $899 / €849. Sales begin on launch day at bambulab.com. 

Technical specifications:

• Build volume: 256 × 256 × 260 mm (single main nozzle) / 235.5 × 256 × 256 mm (dual-nozzle intersection)
• Nozzle temperature: up to 300°C; chamber: up to 65°C
• Triple-stage air filtration (G3 pre-filter + HEPA H12 + activated coconut carbon)
• 31 sensors monitoring filament path, thermal environment, and safety
• Optional Vision Encoder: accuracy down to 50 microns
• PMSM motor with 20 kHz sampling rate
• Noise level below 50 dB

About Bambu Lab

Bambu Lab is a consumer tech innovator dedicated to redefining desktop 3D printing. By creating cutting-edge tools like the groundbreaking X1 series, the company bridges the gap between digital imagination and physical reality, empowering creators worldwide with unprecedented speed and precision.

NYSE issues a pre-market daily advisory direct from the trading floor.

NEW YORK, April 17, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

Ashley Mastronardi delivers the pre-market update on April 17th

• Markets are up Friday morning after President Trump said late Thursday that the conflict in Iran "should be ending pretty soon."
• Aevex (NYSE: AVEX) CEO Roger Wells will join NYSE Live this morning to discuss its strategy as the firm prepares to begin trading on the NYSE.
• Shares of Madison Air (NYSE: MAIR) popped by more than 17% in its first day of trading on the NYSE Thursday.
• Parker Institute of Cancer Immunotherapy CEO Karen Knudsen will join NYSE Live to elaborate on its collaboration with the Cancer Vaccine Coalition.

Opening Bell
Aevex (NYSE: AVEX) celebrates its IPO and NYSE debut

Closing Bell
Pinnacle West Capital (NYSE: PNW) marks its 65^th anniversary of listing

For market insights, IPO activity, and today's opening bell, download the NYSE TV App: TV.NYSE.com

NYSE_Morgan_Stanley

Q1 2026: Solid operational performance and sales

Financial highlights Q1 2026

$2,753 million net sales, increase of 6.8%
0.8% organic sales growth*
8.6% operating margin, 8.9% adj. operating margin*
$1.88 diluted EPS, 12% decrease

Full year 2026 guidance

Around 0% organic sales growth
Around 3% positive FX impact on net sales
Around 10.5-11% adjusted operating margin
Around $1.2 billion operating cash flow

All change figures in this release compare to the same period of the previous year except when stated otherwise.

Key business developments in the first quarter of 2026

• Net sales increased organically* by 0.8%, which was 4.2pp higher than the global LVP decrease of 3.4% (S&P Global Apr 2026) driven mainly by strong progress in Asia. Regional and customer LVP mix is estimated to have impacted sales positively by about 1.5pp, while tariff compensations added around 0.5pp. Our organic sales growth* outperformed LVP significantly in China (15pp) and Asia excl. China (6.8pp) and performed in line in EMEA and underperformed in Americas (4.5pp). Our strong performance in Asia excl. China was mainly due to India, where we outperformed by 28pp, driven by continued strong market growth in safety content per vehicle, while our China performance was mainly driven by further improved presence with Chinese OEMs.
• Profitability was strong. Supported by successful execution of cost reductions and positive FX effects, gross profit increased by 10%. Operating income decreased by 6.7% and adjusted operating income* decreased by 3.9%, impacted by adverse FX translation effects and temporary lower R,D&E reimbursements as well as that Q1 2025 was positively impacted by one-time effects. Operating margin was 8.6% and adjusted operating margin* was 8.9%. ROCE was 22.2% and adjusted ROCE* was 22.9%.
• Operating cash flow was negative $76 million, mainly due to an increase in working capital due to strong sales in March, temporary effects expected to reverse later in the year and the high level of accounts payable at the end of 2025. Free operating cash flow* thereby decreased to negative $159 million. The leverage ratio* was unchanged compared to a year ago at 1.3x, below our target limit of 1.5x. In the quarter, a dividend of $0.87 per share was paid.

*For Non-GAAP measures see enclosed reconciliation tables.

Key Figures

Comments from Mikael Bratt, President & CEO

The first quarter turned out better than we had anticipated, with strong sales in March. Our operational performance exceeded our expectations, with solid productivity improvements, partly supported by reduced call-off volatility. Underlying profitability improved, with gross profit increasing by 10%, although adjusted operating income was slightly lower due to temporary lower R,D&E reimbursements and the one-time income in Q1 last year.

Our positive trend in Asia continued, with strong growth in India, South Korea and China. In China, we continued to grow faster than LVP, especially with the Chinese OEMs, outperforming by 40pp. In India, we grew sales organically by 38%, reflecting mainly the trend of increased safety content in vehicles in India, as well as the continued high level of LVP growth. We continue to expand our production capabilities in India, investing in additional inflator production capacity for future growth.

I am pleased that we in the quarter introduced our first airbag for motorcycles, as well as our first wearable airbag solution for motorcycle riders, building on our long term strategy of growing business outside our traditional core business.

The quarter was characterized by ongoing and new geopolitical challenges. At this point, it is difficult to fully assess the likely impacts, as the situation remains fluid. We continue to carefully monitor the developments while preparing for various scenarios, including different mitigation strategies. 

The business environment is uncertain but our current best estimate for the remainder of the year is a re-iteration of our full year 2026 guidance of about unchanged organic sales and an adjusted operating margin of around 10.5-11%. This is based on the assumption that LVP will decline by around 1%.

Our balance sheet is healthy, with debt leverage of 1.3x, well below our target limit of 1.5x. Based on our guidance for sales and adjusted operating margin, we continue to expect strong cash flow for the year, which supports our ambitions to provide attractive shareholder returns, including to repurchase shares of $300-500 million in 2026.

Next Report

Autoliv intends to publish the quarterly earnings report for the second quarter of 2026 on Friday, July 17, 2026.

Inquiries: Investors and Analysts

Anders Trapp
Vice President Investor Relations
Tel +46 (0)709 578 171

Henrik Kaar
Director Investor Relations
Tel +46 (0)709 578 114

Inquiries: Media

Gabriella Etemad
Senior Vice President Communications
Tel +46 (0)70 612 6424

Autoliv, Inc. is obliged to make this information public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the VP of Investor Relations set out above, at 12.00 CET on April 17, 2026.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/autoliv/r/financial-report-january---march-2026,c4336339

The following files are available for download: